JDRF T1D Fund has made an undisclosed investment in TetraGenetics. Based in Arlington, Massachusetts, TetraGenetics is a biopharmaceutical company developing new treatments for autoimmune diseases. Read more >>
Regroup Mass Notification, the industry-leading provider of emergency and day-to-day mass notification solutions, today announced that it has been…
read moreThanks largely to the kindness of strangers, a GoFundMe campaign helped to raise the money needed to pay for…
read more“Jack and Colleen’s eSight classes have been fully funded,” said Manchester Elementary Principal Molly Lilja in a surprise announcement….
read moreIn its 4th annual beauty study, video advertising technology company, Pixability, reveals its latest beauty space social insights and…
read moreMyomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it…
read moreAras®, the next leader in enterprise Product Lifecycle Management (PLM) software, today announced that LORD Corporation, a leading global…
read moreCorbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics…
read moreThe top-performing public biotech in Massachusetts over the past year is located in a nondescript brick building with no…
read moreMyomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and the Massachusetts Life…
read moreDavin Bazylewski, a Grade 1 student at Bertrun E. Glavin School (116 Antrim Rd.), is legally blind. His family…
read more